Anthony G. Doyle
31Patents
5h-index
40Co-inventors
65Inventor score
Filing activity: Dec 20, 2006 → Sep 3, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10232041B2 | Combination of lenalidomide and polypeptide construct, and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US10138296B2 | Antibodies that specifically bind to TL1A | Chemistry; Metallurgy | 7 | Active |
| US9636334B2 | Combination of lenalidomide and polypeptide construct, and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US8563697B2 | Anti-IL-12/IL-23 antibodies | Chemistry; Metallurgy | 6 | Active |
| US9963515B2 | Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B | Chemistry; Metallurgy | 5 | Active |
| US9611322B2 | Fusions of antibodies to CD38 and attenuated interferon alpha | Chemistry; Metallurgy | 5 | Active |
| US10544199B2 | Interferon alpha 2B variants | Chemistry; Metallurgy | 3 | Active |
| US10822422B2 | Antibodies against TL1a and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11220549B2 | Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases | Chemistry; Metallurgy | 2 | Active |
| US11111292B2 | Anti-IL-5 antibodies | Chemistry; Metallurgy | 1 | Active |
| US11725052B2 | Anti-PAR-2 antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11117975B2 | Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B | Chemistry; Metallurgy | 1 | Active |
| US9127057B2 | Anti-IL-23 heterodimer specific antibodies | Chemistry; Metallurgy | 1 | Active |
| US10981986B2 | Fusions of antibodies to CD38 and attenuated interferon alpha | Chemistry; Metallurgy | 1 | Active |
| US11267883B2 | Antibodies that specifically bind to human IL-15 and uses thereof | Physics | 1 | Active |
| US8470320B2 | Humanised antibodies with anti-tumour activity | Chemistry; Metallurgy | 1 | Active |
| US11253591B2 | Combination of lenalidomide and polypeptide construct, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8901279B2 | Humanized antibodies with anti-tumor activity | Chemistry; Metallurgy | 0 | Active |
| US12281148B2 | Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12358980B2 | Compositions and methods for anti-PACAP antibodies | Chemistry; Metallurgy | 0 | Active |
| US12018084B2 | Anti-CXCR2 antibodies and uses thereof | Physics | 0 | Active |
| US8932588B2 | Treatment of cancer involving mutated KRAS or BRAF genes | Chemistry; Metallurgy | 0 | Active |
| US12384841B2 | Anti-PAR-2 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12410256B2 | Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases | Chemistry; Metallurgy | 0 | Active |
| US12410247B2 | Polynucleotides encoding antibodies that specifically bind to human IL-15 | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.